Entries by pablo

BOPAL’s updates

Following the publication of a new post on our blog, this week we would like to announce that BOPAL is conducting an important study in Chile that involves an inhaled vaccine for COVID-19 as a booster dose in the pediatric and adolescent population, from CanSino Biologics. Inc.   This inhaled vaccine has recently been approved […]

Clinical Trial Planning in Chile

Welcome and thank you for reading BOPAL’s inaugural blog post!   This blog post will be the first in a series that discusses the key high-level timelines to account for when planning a clinical trial to include various countries in Latin America. Because BOPAL is based in Chile, we will start there with today’s post. […]